In part because of its resistance to many antibiotics, tuberculosis kills approximately 1.7 million people worldwide each year. But new research from the University of Notre Dame suggests that structures released by the infected cells may be used in tandem with antibiotics to boost the body’s immune system, helping fight off the disease.
The paper, published in EMBO Reports by Jeffrey Schorey, the George B. Craig Jr. Professor, and Yong Cheng, research assistant professor, both in the Department of Biological Sciences, describes how the structures, called extracellular vesicles (EVs), contain Mycobacterium tuberculosis RNA and transfer it to other cells. This starts a built-in weapon system against the disease in the form of an immune response.
Though extracellular vesicles containing RNA from viruses had been discovered years ago, Schorey and his collaborators recently discovered RNA from bacteria — Mycobacterium tuberculosis — in EVs. This discovery led to experiments described in the EMBO Reports paper to determine how the bacteria’s RNA was affecting the “target” cell, including cells infected by M. tuberculosis.
A key research discovery hinges on macrophages, which are cells of the immune system. These cells, when treated with EVs released from M. tuberculosis-infected cells, can control the infection better than macrophages not previously exposed to the EVs, Schorey and Cheng determined. “It had never before been shown that bacterial RNA in EVs can activate this sensing pathway, one that has primarily been thought to be involved in viral sensing,” Schorey said. The authors then show that EV-treated macrophages produce compounds like reactive oxygen species that can promote the killing of the M. tuberculosis once it infects the macrophage.
The discovery is important because it can lead to future therapies for treatment of tuberculosis. Preliminary data in the paper suggest that antibiotics might work better when combined with an immunotherapy based on using these EVs. The data from the mouse model showed that more of the bacterial-infected cells were killed with the combination of therapies than either antibiotics or EVs alone, Schorey noted.
The next steps for future research are to try this approach with other laboratory models, with the goal that they also show the benefit of combining EVs, as immunotherapy treatments, with antibiotics to treat drug-resistant tuberculosis.
Worldwide, more than 10 million people develop active tuberculosis each year. Furthermore, over two billion people are infected with the bacteria. This results in a reservoir of infected people who may develop disease if their immune systems are compromised.
The Latest on: Tuberculosis
via Google News
The Latest on: Tuberculosis
- Coronavirus Update: Tuberculosis vaccine being tested in Canada for effectiveness against COVID-19on October 6, 2020 at 4:41 pm
Donald Trump continues to play down severity of virus while still infected; First antigen rapid test for COVID-19 approved by Health Canada ...
- Prisoner contracts tuberculosison October 6, 2020 at 10:56 am
"Unfortunately, medical information is not readily given out to staff, and it's a concern of ours that somebody comes in with something transferrable via the atmosphere, and we don't know about it ...
- Canadian researchers begin clinical trials of tuberculosis vaccine for COVID-19on October 6, 2020 at 7:09 am
Researchers in Canada are hoping a century-old vaccine designed to treat tuberculosis can become the key to fighting off a COVID-19 infection.
- Atomwise Receives a $2.3M Grant to Develop New Therapies for Drug Resistant Malaria and Tuberculosison October 6, 2020 at 6:14 am
The $2.3M in grant funding from the Bill & Melinda Gates Foundation will support the development of multiple global health programs to advance novel antimalarial and anti-tuberculosis small molecule ...
- Tuberculosis found in Waikato's Spring Hill prisonon October 5, 2020 at 8:37 pm
There is at least one case of tuberculosis, known as TB, in the Spring Hill prison in North Waikato. Spring Hill Prison director Megan Tuhoro said the secure and controlled nature of the prison ...
- Vaccine for tuberculosis being tested in Canada for effectiveness against COVID-19on October 5, 2020 at 5:56 pm
Researchers suspect the vaccine, known as BCG, primes the body in a general way and enhances its ability to seek out and destroy virus-infected cells ...
- Tuberculosis, still a threat to Filipino childrenon October 4, 2020 at 8:51 pm
Through the campaign #TBFreePH, the Department of Health (DOH) with the help of the United States Agency International Development (USAID) under TB Innovations and Health Systems Strengthening Project ...
- Kwara First Lady partners stakeholders on tuberculosis eradicationon October 1, 2020 at 6:36 am
Mrs Olufolake AbdulRazaq has appealed to stakeholders to support the State Government’s efforts at eradicating Tuberculosis (TB) in the state.
- How Toronto’s first open-air school responded to the tuberculosis crisis more than 100 years agoon September 30, 2020 at 5:29 pm
The third-floor blueprints of Orde Street Public School show several open-air classrooms and an accessible rooftop classroom which remains open to the elements to this day.
- Latent Tuberculosis Infection (LTBI) Testing Market Will Expand at 5.6% CAGR to Cross $ 1540 million by 2025on September 30, 2020 at 9:02 am
Selbyville, Delaware, The ‘ Latent Tuberculosis Infection (LTBI) Testing market’ research report now available ...
via Bing News